Literature DB >> 34041633

Impact of one HF-rTMS session over the DLPFC and motor cortex on acute hormone dynamics and emotional state in healthy adults: a sham-controlled pilot study.

Blair T Crewther1,2, Wiktoria Kasprzycka3, Christian J Cook4,5, Rafał Rola3,6.   

Abstract

Studies indicate that high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) can lower cortisol concentration or output, with some evidence suggesting a link to testosterone. Together, these stress and social hormones might help regulate the emotional response to HF-rTMS. This pilot study evaluated the effect of HF-rTMS on acute testosterone and cortisol dynamics and emotional state in eleven healthy adults. Using a sham-controlled, single-blind, crossover design, participants completed a HF-rTMS session targeting the dorsolateral prefrontal cortex (DLPFC) and motor cortex on separate days. Stimulation (250 total pulses) was applied at 90% of the resting motor threshold. Salivary testosterone and cortisol, mood, motivation, anxiety, and heart rate (HR) were assessed before (T1) and 1 (T2), 15 (T3), and 30 min (T4) after each session. There were no significant session differences in testosterone and cortisol concentration, mood, motivation, and HR. Although DLPFC stimulation produced less anxiety (vs. motor cortex), and testosterone output was stable across both treatments (vs. sham-related decline in testosterone), neither differed from the sham. Within-person fluctuations in testosterone, mood, motivation, and/or anxiety were significantly related across the DLPFC and motor cortex trials only. In conclusion, a single sub-maximal session of HF-rTMS did not affect the hormonal, emotional, or physiological state of healthy adults, relative to a sham. However, the emergence of stimulation-specific testosterone and/or emotional linkages suggests that the repeated effects of HF-rTMS may also manifest at the individual level. This offers another pathway to explain the therapeutic efficacy of rTMS and a model to explore interindividual variability in health-related outcomes.
© 2021. Fondazione Società Italiana di Neurologia.

Entities:  

Keywords:  Cortical; HPA; HPG; Neuromodulation; Steroids; Stress

Mesh:

Substances:

Year:  2021        PMID: 34041633     DOI: 10.1007/s10072-021-05335-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.830


  37 in total

1.  The impact of repetitive transcranial magnetic stimulation on pituitary hormone levels and cortisol in healthy subjects.

Authors:  S Evers; K Hengst; P W Pecuch
Journal:  J Affect Disord       Date:  2001-09       Impact factor: 4.839

2.  Repetitive transcranial magnetic stimulation reduces cortisol concentrations in bulimic disorders.

Authors:  A M Claudino; F Van den Eynde; D Stahl; T Dew; M Andiappan; J Kalthoff; U Schmidt; I C Campbell
Journal:  Psychol Med       Date:  2010-10-07       Impact factor: 7.723

3.  A "hypersensitive" hypothalamic-pituitary-adrenal system could be indicative for a negative clinical high-frequency repetitive transcranial magnetic stimulation outcome in melancholic depressed patients.

Authors:  Chris Baeken; Rudi De Raedt; Marie-Anne Vanderhasselt; Lemke Leyman; Johan Schiettecatte; Kris Poppe; Ellen Anckaert; Axel Bossuyt
Journal:  Brain Stimul       Date:  2009-05-03       Impact factor: 8.955

4.  One left dorsolateral prefrontal cortical HF-rTMS session attenuates HPA-system sensitivity to critical feedback in healthy females.

Authors:  C Baeken; M A Vanderhasselt; J Remue; V Rossi; J Schiettecatte; E Anckaert; R De Raedt
Journal:  Neuropsychologia       Date:  2014-03-01       Impact factor: 3.139

Review 5.  Rehabilitating the addicted brain with transcranial magnetic stimulation.

Authors:  Marco Diana; Tommi Raij; Miriam Melis; Aapo Nummenmaa; Lorenzo Leggio; Antonello Bonci
Journal:  Nat Rev Neurosci       Date:  2017-09-29       Impact factor: 34.870

6.  Deep TMS on alcoholics: effects on cortisolemia and dopamine pathway modulation. A pilot study.

Authors:  Marco Ceccanti; Maurizio Inghilleri; Maria Luisa Attilia; Ruggero Raccah; Marco Fiore; Abraham Zangen; Mauro Ceccanti
Journal:  Can J Physiol Pharmacol       Date:  2015-03-02       Impact factor: 2.273

Review 7.  An endocrine perspective on the role of steroid hormones in the antidepressant treatment efficacy of transcranial magnetic stimulation.

Authors:  Dennis J L G Schutter; Jack van Honk
Journal:  Psychoneuroendocrinology       Date:  2010-01       Impact factor: 4.905

Review 8.  Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).

Authors:  Jean-Pascal Lefaucheur; Nathalie André-Obadia; Andrea Antal; Samar S Ayache; Chris Baeken; David H Benninger; Roberto M Cantello; Massimo Cincotta; Mamede de Carvalho; Dirk De Ridder; Hervé Devanne; Vincenzo Di Lazzaro; Saša R Filipović; Friedhelm C Hummel; Satu K Jääskeläinen; Vasilios K Kimiskidis; Giacomo Koch; Berthold Langguth; Thomas Nyffeler; Antonio Oliviero; Frank Padberg; Emmanuel Poulet; Simone Rossi; Paolo Maria Rossini; John C Rothwell; Carlos Schönfeldt-Lecuona; Hartwig R Siebner; Christina W Slotema; Charlotte J Stagg; Josep Valls-Sole; Ulf Ziemann; Walter Paulus; Luis Garcia-Larrea
Journal:  Clin Neurophysiol       Date:  2014-06-05       Impact factor: 3.708

Review 9.  Neurobiological mechanisms of repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex in depression: a systematic review.

Authors:  Y Noda; W K Silverstein; M S Barr; F Vila-Rodriguez; J Downar; T K Rajji; P B Fitzgerald; B H Mulsant; S N Vigod; Z J Daskalakis; D M Blumberger
Journal:  Psychol Med       Date:  2015-09-09       Impact factor: 7.723

Review 10.  Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018).

Authors:  Jean-Pascal Lefaucheur; André Aleman; Chris Baeken; David H Benninger; Jérôme Brunelin; Vincenzo Di Lazzaro; Saša R Filipović; Christian Grefkes; Alkomiet Hasan; Friedhelm C Hummel; Satu K Jääskeläinen; Berthold Langguth; Letizia Leocani; Alain Londero; Raffaele Nardone; Jean-Paul Nguyen; Thomas Nyffeler; Albino J Oliveira-Maia; Antonio Oliviero; Frank Padberg; Ulrich Palm; Walter Paulus; Emmanuel Poulet; Angelo Quartarone; Fady Rachid; Irena Rektorová; Simone Rossi; Hanna Sahlsten; Martin Schecklmann; David Szekely; Ulf Ziemann
Journal:  Clin Neurophysiol       Date:  2020-01-01       Impact factor: 3.708

View more
  2 in total

1.  Bilateral repetitive transcranial magnetic stimulation ameliorated sleep disorder and hypothalamic-pituitary-adrenal axis dysfunction in subjects with major depression.

Authors:  Xing Chen; Fei Jiang; Qun Yang; Peiyun Zhang; Haijiao Zhu; Chao Liu; Tongtong Zhang; Weijun Li; Jian Xu; Hongmei Shen
Journal:  Front Psychiatry       Date:  2022-08-25       Impact factor: 5.435

2.  Combined repetitive transcranial magnetic stimulation and medication treatment for depression is associated with serum amyloid a level: Evidence from naturalistic clinical practice.

Authors:  You Xu; Li Han; Youdan Wei; Hongjing Mao; Zhenghe Yu
Journal:  Front Neurosci       Date:  2022-09-14       Impact factor: 5.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.